C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B
Open Access
- 15 February 2000
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 19 (4) , 612-622
- https://doi.org/10.1093/emboj/19.4.612
Abstract
Dominantly inherited multiple endocrine neoplasia type 2B (MEN2B) is characterized by tumors of the thyroid C‐cells and adrenal chromaffin cells, together with ganglioneuromas of the gastrointestinal tract and other developmental abnormalities. Most cases are caused by substitution of threonine for Met918 in the RET receptor tyrosine kinase, which is believed to convert the RET gene to an oncogene by altering the enzyme's substrate specificity. We report the production of a mouse model of MEN2B by introduction of the corresponding mutation into the ret gene. Mutant mice displayed C‐cell hyperplasia and chromaffin cell hyperplasia progressing to pheochromocytoma. Homozygotes did not develop gastrointestinal ganglioneuromas, but displayed ganglioneuromas of the adrenal medulla, enlargement of the associated sympathetic ganglia and a male reproductive defect. Surprisingly, homozygotes did not display any developmental defects attributable to a loss‐of‐function mutation. Thus, while our results support the conclusion that the Met918Thr substitution is responsible for MEN2B, they suggest that the substrate specificity of the RET kinase does not interfere with its normal role in the development of the kidneys and enteric nervous system.Keywords
This publication has 55 references indexed in Scilit:
- Enhanced Phosphatidylinositol 3-Kinase Activity and High Phosphorylation State of Its Downstream Signalling Molecules Mediated by Ret with the MEN 2B MutationBiochemical and Biophysical Research Communications, 1999
- Cre–mediated chromosome loss in miceNature Genetics, 1997
- Germline mutation of RET codon 883 in two cases of de novo MEN 2BOncogene, 1997
- Ret in human development and oncogenesisBioEssays, 1997
- Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutationsOncogene, 1997
- Immunohistochemical and Morphological Characterization of Spontaneously Occurring Pheochromocytomas in the Aging MouseVeterinary Pathology, 1996
- The Multiple Endocrine Neoplasia Type 2B Point Mutation Alters Long-term Regulation and Enhances the Transforming Capacity of the Epidermal Growth Factor ReceptorPublished by Elsevier ,1996
- Catalytic specificity of protein-tyrosine kinases is critical for selective signallingNature, 1995
- Oncogenic Activation of the ret Protooncogene in Thyroid CancerCritical Reviews™ in Oncogenesis, 1995
- Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHuman Molecular Genetics, 1993